269 related articles for article (PubMed ID: 9112381)
21. Specific induction of a functional endogenous D2 short dopamine receptor in GH4C1 cells.
Allard S; Lapointe S; Falardeau P
Biochem Biophys Res Commun; 1993 Jun; 193(2):801-7. PubMed ID: 8390254
[TBL] [Abstract][Full Text] [Related]
22. Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3',5'-monophosphate production in lactotroph cells.
Audinot V; Rasolonjanahary R; Bertrand P; Priam M; Kordon C; Enjalbert A
Endocrinology; 1991 Oct; 129(4):2231-9. PubMed ID: 1655395
[TBL] [Abstract][Full Text] [Related]
23. Turkey prolactin gene regulation by VIP through 35-bp cis-acting element in the proximal promoter.
Kang SW; Gazzillo LC; You S; Wong EA; El Halawani ME
Gen Comp Endocrinol; 2004 Sep; 138(2):157-65. PubMed ID: 15302265
[TBL] [Abstract][Full Text] [Related]
24. G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells.
Albert PR
Mol Endocrinol; 2002 Aug; 16(8):1903-11. PubMed ID: 12145343
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
26. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S
Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121
[TBL] [Abstract][Full Text] [Related]
27. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats.
Rendt J; Oxford GS
Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors.
Seabrook GR; Knowles M; Brown N; Myers J; Sinclair H; Patel S; Freedman SB; McAllister G
Br J Pharmacol; 1994 Jul; 112(3):728-34. PubMed ID: 7921596
[TBL] [Abstract][Full Text] [Related]
29. Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3',5'-monophosphate-stimulated prolactin secretion.
Taylor AD; Philip JG; John CD; Cover PO; Morris JF; Flower RJ; Buckingham JC
Endocrinology; 2000 Jun; 141(6):2209-19. PubMed ID: 10830310
[TBL] [Abstract][Full Text] [Related]
30. Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene.
Romano D; Magalon K; Ciampini A; Talet C; Enjalbert A; Gerard C
J Biol Chem; 2003 Dec; 278(51):51386-94. PubMed ID: 14551200
[TBL] [Abstract][Full Text] [Related]
31. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
32. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling.
Al Kahtane A; Kannan M; Kang SW; El Halawani ME
J Neuroendocrinol; 2005 Oct; 17(10):649-55. PubMed ID: 16159377
[TBL] [Abstract][Full Text] [Related]
33. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
[TBL] [Abstract][Full Text] [Related]
34. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7).
Nilsson C; Eriksson E
Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
Coleman DT; Chen X; Sassaroli M; Bancroft C
Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
[TBL] [Abstract][Full Text] [Related]
36. The D2 receptor: blocked transcription in GH3 cells and cellular pathways employed by D2A to regulate prolactin promoter activity.
Fischberg DJ; Bancroft C
Mol Cell Endocrinol; 1995 Jun; 111(2):129-37. PubMed ID: 7556874
[TBL] [Abstract][Full Text] [Related]
37. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
[TBL] [Abstract][Full Text] [Related]
38. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
Munemura M; Agui T; Sibley DR
Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
[TBL] [Abstract][Full Text] [Related]
39. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
[TBL] [Abstract][Full Text] [Related]
40. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
